Prognostic Value of Percent Gleason Grade 4 at Prostate Biopsy in Predicting Prostatectomy Pathology and Recurrence.

[1]  Arkadiusz Gertych,et al.  A Multi-scale U-Net for Semantic Segmentation of Histological Images from Radical Prostatectomies , 2017, AMIA.

[2]  J. Melamed,et al.  Size-adjusted Quantitative Gleason Score as a Predictor of Biochemical Recurrence after Radical Prostatectomy. , 2016, European urology.

[3]  J. Epstein,et al.  Changes in prostate cancer grading: Including a new patient‐centric grading system , 2016, The Prostate.

[4]  L. Egevad,et al.  A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score. , 2016, European urology.

[5]  B. Delahunt,et al.  The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System , 2015, The American journal of surgical pathology.

[6]  A. D'Amico,et al.  Risk Group and Death From Prostate Cancer Among Men Undergoing Brachytherapy , 2015 .

[7]  A. D'Amico,et al.  Risk Group and Death From Prostate Cancer: Implications for Active Surveillance in Men With Favorable Intermediate-Risk Prostate Cancer. , 2015, JAMA oncology.

[8]  David C. Miller,et al.  MP1-14 DEFINING ADVERSE PATHOLOGY FOR LOWER RISK MEN UNDERGOING RADICAL PROSTATECTOMY , 2015 .

[9]  Baris Turkbey,et al.  Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. , 2015, JAMA.

[10]  Danny Vesprini,et al.  Long-term follow-up of a large active surveillance cohort of patients with prostate cancer. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  John T. Wei,et al.  Impact of tertiary Gleason pattern 5 on prostate cancer aggressiveness: Lessons from a contemporary single institution radical prostatectomy series , 2014, Asian journal of urology.

[12]  William L. Welbourn,et al.  Prognostic utility of the cell cycle progression score generated from biopsy in men treated with prostatectomy. , 2014, The Journal of urology.

[13]  Fang-Ming Deng,et al.  Gleason Score 3 + 4=7 Prostate Cancer With Minimal Quantity of Gleason Pattern 4 on Needle Biopsy Is Associated With Low-risk Tumor in Radical Prostatectomy Specimen , 2014, The American journal of surgical pathology.

[14]  A. Renshaw,et al.  The likelihood of death from prostate cancer in men with favorable or unfavorable intermediate‐risk disease , 2014, Cancer.

[15]  Alan W Partin,et al.  Prognostic Gleason grade grouping: data based on the modified Gleason scoring system , 2013, BJU international.

[16]  Y. Yamada,et al.  Prognostic importance of Gleason 7 disease among patients treated with external beam radiation therapy for prostate cancer: results of a detailed biopsy core analysis. , 2013, International journal of radiation oncology, biology, physics.

[17]  D. Dabbs,et al.  Prediction of the Oncotype DX recurrence score: use of pathology-generated equations derived by linear regression analysis , 2013, Modern Pathology.

[18]  D. Kuban,et al.  Is androgen deprivation therapy necessary in all intermediate-risk prostate cancer patients treated in the dose escalation era? , 2011, International journal of radiation oncology, biology, physics.

[19]  M. Cooperberg,et al.  The quantitative Gleason score improves prostate cancer risk assessment , 2012, Cancer.

[20]  Christopher U. Jones,et al.  Radiotherapy and short-term androgen deprivation for localized prostate cancer. , 2011, The New England journal of medicine.

[21]  C. D’Este,et al.  Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial. , 2011, The Lancet. Oncology.

[22]  M. Kattan,et al.  Predictive and prognostic models in radical prostatectomy candidates: a critical analysis of the literature. , 2010, European urology.

[23]  Jing Ma,et al.  Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3? , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  Alan W Partin,et al.  Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005. , 2007, Urology.

[25]  T. H. van der Kwast,et al.  Should we replace the Gleason score with the amount of high-grade prostate cancer? , 2007, European urology.

[26]  B. Leibovich,et al.  Long-term prognostic significance of primary Gleason pattern in patients with Gleason score 7 prostate cancer: impact on prostate cancer specific survival. , 2006, The Journal of urology.

[27]  A. D'Amico,et al.  Predictors of prostate cancer-specific mortality after radical prostatectomy or radiation therapy. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  L. Egevad,et al.  The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma , 2005, The American journal of surgical pathology.

[29]  J. Manola,et al.  6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: a randomized controlled trial. , 2004, JAMA.

[30]  D. Lubeck,et al.  Predicting recurrence after radical prostatectomy for patients with high risk prostate cancer. , 2003, The Journal of urology.

[31]  T. Stamey,et al.  Biological determinants of cancer progression in men with prostate cancer. , 1999, JAMA.